• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地中海贫血中的胰岛素依赖型糖尿病

Insulin dependent diabetes in thalassaemia.

作者信息

De Sanctis V, Zurlo M G, Senesi E, Boffa C, Cavallo L, Di Gregorio F

机构信息

Paediatric Division, Arcispedale S Anna, Ferrara.

出版信息

Arch Dis Child. 1988 Jan;63(1):58-62. doi: 10.1136/adc.63.1.58.

DOI:10.1136/adc.63.1.58
PMID:3348650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1779356/
Abstract

Diabetes mellitus was observed in 29 of 448 patients with thalassaemia major attending seven Italian centres. Twelve patients, at onset of clinical diabetes, presented with an asymptomatic glycosuria, 13 with ketosis, and four with ketoacidosis. All were diagnosed after 1979, at a mean age of 17 years. Mean age at diagnosis of diabetes was lower in patients born in the last two decades. In these patients transfusions were started at a younger age and pre-transfusion haemoglobin concentration, serum ferritin concentration, incidence of liver disease, and the presence of a family history of diabetes were higher than in patients born previously. Although 27 (93%) cases had iron chelating treatment the mean serum ferritin concentration was 5600 micrograms/l; 25 (92%) of these patients had signs of liver impairment. The determination of C peptide in 10 patients showed a wide variation in pancreatic beta cell function, and insulin requirements ranged between 0.15 and 1.72 U/kg body weight. Metabolic control was generally poor. The onset of diabetes mellitus was followed in most patients by the appearance of other endocrine or cardiac complications, or both. Fourteen patients died within three years of presenting with overt diabetes. Haemosiderosis, liver infections, and genetic factors seemed to be crucial in diabetes development. Thalassaemic patients developing clinical diabetes mellitus are at high risk for other complications and should be strictly monitored, especially for thyroid impairment.

摘要

在七个意大利中心就诊的448例重型地中海贫血患者中,有29例观察到患有糖尿病。12例临床糖尿病发病患者表现为无症状性糖尿,13例有酮症,4例有酮症酸中毒。所有患者均于1979年后确诊,平均年龄为17岁。过去二十年出生的患者中糖尿病诊断时的平均年龄较低。在这些患者中,输血开始的年龄较小,输血前血红蛋白浓度、血清铁蛋白浓度、肝病发生率以及糖尿病家族史的存在情况均高于以前出生的患者。尽管27例(93%)患者接受了铁螯合治疗,但平均血清铁蛋白浓度仍为5600微克/升;其中25例(92%)患者有肝功能损害迹象。对10例患者的C肽测定显示胰腺β细胞功能差异很大,胰岛素需求量在0.15至1.72单位/千克体重之间。代谢控制总体较差。大多数患者糖尿病发病后出现了其他内分泌或心脏并发症,或两者皆有。14例患者在出现明显糖尿病后三年内死亡。含铁血黄素沉着症、肝脏感染和遗传因素似乎在糖尿病发展中起关键作用。发生临床糖尿病的地中海贫血患者发生其他并发症的风险很高,应进行严格监测,尤其是甲状腺功能损害。

相似文献

1
Insulin dependent diabetes in thalassaemia.地中海贫血中的胰岛素依赖型糖尿病
Arch Dis Child. 1988 Jan;63(1):58-62. doi: 10.1136/adc.63.1.58.
2
Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.重型地中海贫血内分泌并发症患病率的多中心研究。意大利非内分泌疾病内分泌并发症工作组。
Clin Endocrinol (Oxf). 1995 Jun;42(6):581-6. doi: 10.1111/j.1365-2265.1995.tb02683.x.
3
Diabetes mellitus in children suffering from beta-thalassaemia.
J Trop Pediatr. 1994 Oct;40(5):261-6. doi: 10.1093/tropej/40.5.261.
4
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore.新加坡输血依赖型地中海贫血患者的临床和健康相关生活质量结果。
Blood Cells Mol Dis. 2021 May;88:102547. doi: 10.1016/j.bcmd.2021.102547. Epub 2021 Feb 9.
5
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.接受输血和去铁胺治疗的重型地中海贫血患者的生存情况及并发症
Haematologica. 2004 Oct;89(10):1187-93.
6
[Clinico-therapeutic findings on diabetic complications in thalassemia].[地中海贫血患者糖尿病并发症的临床治疗研究结果]
Pediatr Med Chir. 1984 Nov-Dec;6(6):765-7.
7
Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).重型地中海贫血患者内分泌并发症及身材矮小的患病率:地中海贫血国际联合会(TIF)的一项多中心研究
Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:249-55.
8
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.性腺功能减退、糖尿病、甲状腺功能减退、甲状旁腺功能减退:1980年至2007年在费拉拉中心随访的重型地中海贫血患者中与铁过载及螯合疗法相关的发病率和患病率
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69.
9
Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.重型地中海贫血患者中的糖尿病和糖耐量受损:费拉拉中心随访患者的发病率、患病率、危险因素及生存率
Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:285-91.
10
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.血清铁蛋白在预测依赖输血的地中海贫血患者对去铁胺治疗的肝脏铁浓度反应方面的局限性。
Eur J Haematol. 2017 Mar;98(3):280-288. doi: 10.1111/ejh.12830. Epub 2017 Jan 13.

引用本文的文献

1
Pregnancy outcomes and iron status in β-thalassemia major and intermedia: a systematic review and meta-analysis.β-地中海贫血重型和中间型妊娠结局和铁状态:系统评价和荟萃分析。
Blood Adv. 2024 Feb 13;8(3):746-757. doi: 10.1182/bloodadvances.2023011636.
2
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.β-地中海贫血合并糖尿病患者使用口服降糖药物:ICET-A 网络回顾性研究的初步数据。
Acta Biomed. 2022 May 11;93(2):e2022162. doi: 10.23750/abm.v93i2.12056.
3
The clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM).25 例输血依赖型β-地中海贫血(TDT)患者近期被诊断为糖尿病(DM)后的临床特征、生化参数和口服葡萄糖耐量试验(OGTT)的胰岛素反应。
Acta Biomed. 2022 Jan 19;92(6):e2021488. doi: 10.23750/abm.v92i6.12366.
4
A Perception on Genome-Wide Genetic Analysis of Metabolic Traits in Arab Populations.关于阿拉伯人群代谢性状全基因组遗传分析的见解
Front Endocrinol (Lausanne). 2019 Jan 28;10:8. doi: 10.3389/fendo.2019.00008. eCollection 2019.
5
Protective effects of deferasirox and N-acetyl-L-cysteine on iron overload-injured bone marrow.地拉罗司和N-乙酰半胱氨酸对铁过载损伤骨髓的保护作用。
Braz J Med Biol Res. 2017 Oct 19;50(12):e6087. doi: 10.1590/1414-431X20176087.
6
The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.重型地中海贫血患者葡萄糖稳态紊乱诊断与管理的ICET-A建议
Mediterr J Hematol Infect Dis. 2016 Oct 28;8(1):e2016058. doi: 10.4084/MJHID.2016.058. eCollection 2016.
7
A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk.非简并性的孟德尔遗传位点有害变异编码有助于复杂疾病风险。
Cell. 2013 Sep 26;155(1):70-80. doi: 10.1016/j.cell.2013.08.030.
8
Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.使用连续血糖监测和口服葡萄糖耐量试验检测重型β地中海贫血青少年和青年成人的血糖异常:初步研究
Indian J Endocrinol Metab. 2013 May;17(3):490-5. doi: 10.4103/2230-8210.111647.
9
Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets.缺氧诱导因子-1α调节小鼠和人胰岛β细胞功能。
J Clin Invest. 2010 Jun;120(6):2171-83. doi: 10.1172/JCI35846. Epub 2010 May 3.
10
Iron overload in patients with myelodysplastic syndromes.骨髓增生异常综合征患者的铁过载。
Curr Hematol Malig Rep. 2007 Feb;2(1):13-21. doi: 10.1007/s11899-007-0003-5.

本文引用的文献

1
New approaches to the transfusion management of thalassemia.地中海贫血输血管理的新方法。
Blood. 1980 Jan;55(1):55-60.
2
Haemoglobin levels and blood requirement in thalassaemia.地中海贫血患者的血红蛋白水平及血液需求量
Arch Dis Child. 1982 Feb;57(2):156-8. doi: 10.1136/adc.57.2.156.
3
Insulin resistance and iron overload.胰岛素抵抗与铁过载。
Ann Clin Biochem. 1983 Mar;20 Pt 2:77-9. doi: 10.1177/000456328302000203.
4
Diabetes mellitus and primary hypothyroidism.糖尿病和原发性甲状腺功能减退症。
Metabolism. 1968 Feb;17(2):108-13. doi: 10.1016/0026-0495(68)90136-4.
5
An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.正常受试者、缺铁患者及铁过载患者血清中铁蛋白的免疫放射分析。
J Clin Pathol. 1972 Apr;25(4):326-9. doi: 10.1136/jcp.25.4.326.
6
Carbohydrate homeostasis and pancreatic islet cell funtion in thalassemia.地中海贫血中的碳水化合物稳态与胰岛细胞功能
Ann Intern Med. 1974 Jan;80(1):65-9. doi: 10.7326/0003-4819-80-1-65.
7
The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.长期螯合治疗的β地中海贫血患者糖尿病和慢性肝病的发生情况。
Postgrad Med J. 1986 Sep;62(731):831-6. doi: 10.1136/pgmj.62.731.831.
8
Hormonal changes in thalassaemia major.重型地中海贫血的激素变化。
Arch Dis Child. 1976 Nov;51(11):828-36. doi: 10.1136/adc.51.11.828.
9
Red-cell aggregation and red-cell deformability in diabetes.糖尿病中的红细胞聚集与红细胞变形性
Diabetes. 1976;25(2 SUPPL):897-902.
10
Abnormal glucose tolerance in beta-thalassemia major.重型β地中海贫血患者的糖耐量异常。
Metabolism. 1977 Jan;26(1):43-52. doi: 10.1016/0026-0495(77)90126-3.